Axogen Finalizes $124M Common Stock Offering at Discount, Repays Credit Facility

summarizeSummary

Axogen, Inc. finalized an underwritten public offering of 4 million shares of common stock at $31.00 per share, raising $124 million, with an option for an additional $18.6 million, primarily to repay its credit facility.

check_boxKey Events

• Finalizes Common Stock Offering

  Axogen finalized an underwritten public offering of 4,000,000 shares of common stock at $31.00 per share, raising $124 million.

• Underwriters' Over-Allotment Option

  Underwriters have a 30-day option to purchase an additional 600,000 shares, potentially increasing total proceeds by $18.6 million.

• Strategic Debt Repayment

  Approximately $69.7 million of the net proceeds will be used for the early payoff and termination of the company's credit facility.

• Share Dilution

  The offering, priced at a discount to recent market prices, will result in immediate and substantial dilution for existing shareholders.

auto_awesomeAnalysis

This 424B5 filing finalizes the terms and pricing of a significant common stock offering, which was initiated on January 21, 2026. The offering of 4 million shares at $31.00 per share, with an additional 600,000 shares option, could raise up to $142.6 million. This represents a substantial capital raise, leading to nearly 10% dilution for existing shareholders. A significant portion of the net proceeds, approximately $69.7 million, is allocated for the early payoff and termination of the company's credit facility, which is a positive step for balance sheet health and reducing financial risk. The offering price of $31.00 per share is at a discount to the last reported sale price of $33.01 on January 21, 2026, and today's price of $32.00.